Navigation Links
Rutgers, UMDNJ receive $23 million to develop antidotes for chemical weapons attacks
Date:9/13/2011

The National Institutes of Health (NIH) has awarded a five-year $23.2 million grant to a group of investigators at Rutgers University and the University of Medicine and Dentistry of New Jersey (UMDNJ)-Robert Wood Johnson Medical School to continue their research aimed at developing drug products that could be used against chemical warfare agents from a terrorist attack.

Members of the Environmental and Occupational Health Sciences Institute (EOHSI), Rutgers and UMDNJ-Robert Wood Johnson Medical School have been collaborating with scientists from the School of Public Health at New York Medical College and the Chemistry Department at Lehigh University for the past five years to devise therapies that could be used if deadly chemical poisons were released into the general population.

The focus of the research is the development of drugs to treat individuals exposed to mustard gas. The newly awarded funding allows these investigators who are part of the UMDNJ/Rutgers CounterACT Research Center of Excellence the opportunity to continue work begun in 2006 after the NIH granted Rutgers and UMDNJ-Robert Wood Johnson Medical School $19.2 million to establish the center and begin its research.

"This funding allows our us to continue our considerable efforts with different research groups to develop drug products that can be used successfully against a chemical terrorist attack," said Jeffrey Laskin, Professor of Environmental and Occupational Medicine at Robert Wood Johnson Medical School, and director of the center. "This is critical to preventing serious injury and death from any such attack."

The focus of the center's research is the development of drug products to treat individuals exposed to mustard gas, which causes symptoms ranging from skin irritations and conjunctivitis to severe ulcerations, blistering of the skin, blindness and irreversible damage to the respiratory tract and lungs. Mustard gas was first used by the German military against Allied troops during World War I and more recently in the Iran-Iraq conflict during the 1980s. It is easy to make and transport and is still considered a high risk terrorist threat.

"We were asked if we could apply our expertise to help address this type of national security issue," said Laskin. "There has been a lot of conversation over the years about the problems that could result from a terrorist attack and everyone realized that we needed to develop a therapy to counteract this if it happens."

The principal investigators in the UMDNJ/Rutgers CounterACT Research Center of Excellence include Director Jeffrey Laskin of UMDNJ, Co-Director Donald Gerecke at Rutgers Ernest Mario School of Pharmacy, Marion Gordon, Debra Laskin and Patrick Sinko, also at Rutgers School of Pharmacy, Diane Heck at New York Medical College, and Ned Heindel at Lehigh University. They work closely with Batelle Laboratory in Ohio, where mustard gas experiments are carried out.


'/>"/>

Contact: Robin Lally
rlally@ur.rutgers.edu
732-932-7084 x652
Rutgers University
Source:Eurekalert

Related biology news :

1. TAXIS Pharmaceuticals licenses novel antimicrobial technology from Rutgers and UMDNJ
2. LCC science projects receive $1.2 million through WaterSMART program
3. NJIT professor working with graphene, carbon nanotubes to receive honor
4. Danforth Center Collaborative Research Program receives funding to improve crop yield in Africa
5. Marine Science Institute receives $7 Million grant to study the impact of the Deepwater Horizon
6. UC Riverside plant biotechnologist receives prestigious Jefferson Science Fellowship
7. Scientists receive grant to develop new DNA sequencing method
8. Hawaii receives funding for liver cancer research
9. CWRU School of Dental Medicine receives $2.6 million in grants
10. Mount Sinai receives $3.4 million for largest study of personalized medicine in the clinical setting
11. MegaMatcher and VeriFinger SDK Fingerprint Compression Algorithms Receive WSQ Certification from FBI Biometric Center of Excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
(Date:6/2/2016)... June 2, 2016 Perimeter Surveillance ... Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... will generate revenues of $17.98 billion in 2016. ... Inc, a leader in software and hardware technologies for ...
(Date:5/24/2016)... May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology ... LCD display is the latest premium product recently added to the range of products ... ... ... 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission ... hardware projects are designed, built and brought to market. , The Design Lab ...
(Date:6/23/2016)... NEWPORT BEACH, Calif. , June 23, 2016 /PRNewswire/ ... offering new biological discoveries to the medical community, has ... and co-founder Matthew Nunez . "We ... provide us with the capital we need to meet ... funding will essentially provide us the runway to complete ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology: